Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38015220

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA
Publication date
2023 Nov 28
First author
Mai HQ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA. 2023 Nov 28;330(20):1954-1955. doi: 10.1001/jama.2023.22465.
    note
    Source null
    related pmid
    38015229
    relationship
    Comment in
  2. citation
    Lancet. 2024 Jun 22;403(10445):2667-2669. doi: 10.1016/S0140-6736(24)00810-9.
    note
    Source null
    related pmid
    38824939
    relationship
    Comment in

Authors and identifiers

  1. name
    Mai HQ
    type
    Author
  2. name
    Chen QY
    type
    Author
  3. name
    Chen D
    type
    Author
  4. name
    Hu C
    type
    Author
  5. name
    Yang K
    type
    Author
  6. name
    Wen J
    type
    Author
  7. name
    Li J
    type
    Author
  8. name
    Shi Y
    type
    Author
  9. name
    Jin F
    type
    Author
  10. name
    Xu R
    type
    Author
  11. name
    Pan J
    type
    Author
  12. name
    Qu S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mai HQ
    type
    Author
  2. name
    Chen QY
    type
    Author
  3. name
    Chen D
    type
    Author
  4. name
    Hu C
    type
    Author
  5. name
    Yang K
    type
    Author
  6. name
    Wen J
    type
    Author
  7. name
    Li J
    type
    Author
  8. name
    Shi Y
    type
    Author
  9. name
    Jin F
    type
    Author
  10. name
    Xu R
    type
    Author
  11. name
    Pan J
    type
    Author
  12. name
    Qu S
    type
    Author
bibliography ids
  1. nci-bib-de91908574a7976fd7062b74
book metadata
content sha256
ce1f12391e1ca7b1c36f1b1c9b6c0bcfef1dad49a193bc43b41bf37e37750beb
document type
citation
dois
  1. 10.1001/jama.2023.20181
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:38015220
immutable id
pubmed:38015220@ce1f12391e1ca7b1c36f1b1c9b6c0bcfef1dad49a193bc43b41bf37e37750beb
journal
abbreviation
JAMA
issn electronic
1538-3598
issn print
0098-7484
issue
20
name
JAMA
nlm unique id
7501160
pages
1961-1970
volume
330
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA. 2023 Nov 28;330(20):1954-1955. doi: 10.1001/jama.2023.22465.
    note
    Source null
    related pmid
    38015229
    relationship
    Comment in
  2. citation
    Lancet. 2024 Jun 22;403(10445):2667-2669. doi: 10.1016/S0140-6736(24)00810-9.
    note
    Source null
    related pmid
    38824939
    relationship
    Comment in
outcomes validated
false
pmid
38015220
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
a2a22edb2d8a7a3a6136fa4e7ef9a6afb487d556a5f69fcd6df59d7ffc23cac7
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2023 Nov 28
precision
day
year
2023
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38015220/
title
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.

Preserved source evidence · Not medical advice